Baidu-Backed BioMap Files for HK IPO

🔑 Enhanced Key Takeaways

• •BioMap was co-founded by Baidu founder Robin Li Yanhong.
• •BioMap's xTrimo is the world's first 268B-parameter life science AI foundation model, trained on over 6 billion proteins and trillions of single-cell measurements.
• •BioMap specializes in AI-driven target identification and novel antibody modalities for immuno-oncology and autoimmune diseases, recognized as a World Economic Forum Technology Pioneer in 2022.
• •The company operates a world-leading super-computing center and 100,000 sq ft AI-centric high-throughput wet labs to support model training.

🛠️ Technical Deep Dive

• •xTrimo family: Cross-Modal Transformer Representation of Interactome and Multi-Omics pre-trained large language models.
• •Training data: Curated proprietary datasets with >6 billion proteins, 100 billion protein-protein interactions, trillions of single-cell gene expression from 100+ million cells.
• •Scale: First life science AI foundation model to exceed 100 billion parameters, reaching 268B in xTrimo V4.
• •Applications: Enables task models for therapeutic antibodies (e.g., ImmuBot® multifunctional immunotherapy), industrial enzymes, next-generation biologics against undruggable targets with limited/zero labeled data.
• •Infrastructure: World-leading super-computing center paired with 100,000 sq ft high-throughput wet labs for real-world patient and automated lab data generation.

🔮 Future ImplicationsAI analysis grounded in cited sources

⏳ Timeline